Perspective Therapeutics, Inc. — Director's Dealing 2019

Sep 20, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-09-11

Reporting Person: Cline Krista (Dir. of Operations, Secretary)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1033	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$0.2600	2019-06-01	Common Stock (21900)		Direct
Stock Options (right to buy)	$1.4300	2020-06-30	Common Stock (20000)		Direct
Stock Options (right to buy)	$0.9900	2021-06-07	Common Stock (20000)		Direct
Stock Options (right to buy)	$0.9800	2022-06-27	Common Stock (7500)		Direct
Stock Options (right to buy)	$0.5900	2023-09-06	Common Stock (5000)		Direct
Stock Options (right to buy)	$2.4600	2024-06-17	Common Stock (20000)		Direct
Stock Options (right to buy)	$0.6050	2027-06-27	Common Stock (75000)		Direct
Stock Options (right to buy)	$0.4600	2028-06-13	Common Stock (50000)		Direct

Footnotes

F1: Fully Vested 6/1/2013

F2: Fully Vested 6/30/2014

F3: Fully Vested 6/7/2015

F4: Fully Vested 6/27/2016

F5: Fully Vested 9/6/2017

F6: Fully Vested 6/17/2018

F7: 25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested.

F8: 25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested.